Park Jung-Hyun, Yu Qing, Erman Batu, Appelbaum Jacob S, Montoya-Durango Diego, Grimes H Leighton, Singer Alfred
Experimental Immunology Branch, National Cancer Institute, Building 10 Room 4B36, Bethesda, Maryland 20892, USA.
Immunity. 2004 Aug;21(2):289-302. doi: 10.1016/j.immuni.2004.07.016.
Survival of naive T cells is dependent upon IL-7, which is present in vivo in limiting amounts with the result that naive T cells must compete for IL-7-mediated survival signals. It would seem imperative during T cell homeostasis that limiting IL-7 be shared by the greatest possible number of T cells. We now describe a novel regulatory mechanism that specifically suppresses IL7Ralpha transcription in response to IL-7 and other prosurvival cytokines (IL-2, IL-4, IL-6, and IL-15). Consequently, IL7R expression is reduced on T cells that have received cytokine-mediated survival signals so they do not compete with unsignaled T cells for remaining IL-7. Interestingly, cytokine-mediated suppression of IL7Ralpha transcription involves different molecular mechanisms in CD4+ and CD8+ T cells, as CD8+ T cells utilize the transcriptional repressor GFI1 while CD4+ T cells do not. We suggest that this homeostatic regulatory mechanism promotes survival of the maximum possible number of T cells for the amount of IL-7 available.
初始T细胞的存活依赖于IL-7,IL-7在体内含量有限,结果是初始T细胞必须竞争IL-7介导的存活信号。在T细胞稳态过程中,似乎至关重要的是,有限的IL-7应由尽可能多的T细胞共享。我们现在描述一种新的调节机制,该机制可响应IL-7和其他促存活细胞因子(IL-2、IL-4、IL-6和IL-15)特异性抑制IL7Rα转录。因此,已接收细胞因子介导的存活信号的T细胞上的IL7R表达降低,这样它们就不会与未接收到信号的T细胞竞争剩余的IL-7。有趣的是,细胞因子介导的对IL7Rα转录的抑制在CD4+和CD8+ T细胞中涉及不同的分子机制,因为CD8+ T细胞利用转录抑制因子GFI1,而CD4+ T细胞则不然。我们认为,这种稳态调节机制在现有IL-7量的情况下促进了尽可能多的T细胞存活。